AMPH vs COO: fair value comparison
Amphastar Pharmaceuticals, Inc. and The Cooper Companies, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, AMPH currently sits closer to the top of our discount ranking. COO carries the stronger quality grade.
| AMPH | COO | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $20.22 | $71.17 |
| 12-month range | $18.42–$30.81 | $60.19–$83.92 |
| Sector rank | #15 of 113 Healthcare | #16 of 113 Healthcare |
| Quality grade | C- | A |
| Momentum grade | A | A |
| Leverage | Moderate | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The bottom quarter | The lower-middle quarter |
Full single-stock breakdowns: AMPH fair value analysis · COO fair value analysis